R&D and Product Engineering in Global Pharmaceutical Companies

Abstract

In the global pharmaceutical market, innovation and imitation processes play a key role in companies’ development policies. Through the analysis of the main pharmaceutical companies (originator and generic pharmaceutical companies), this paper aims to identify features that qualify companies themselves, with a particular focus on new product R&D processes.